WO2026098515 - PCSK9 CYCLIC PEPTIDE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/098515
Publication Date
15.05.2026
International Application No.
PCT/CN2025/132792
International Filing Date
05.11.2025
Title **
[English]
PCSK9 CYCLIC PEPTIDE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
[French]
INHIBITEUR PEPTIDIQUE CYCLIQUE DE PCSK9, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
一种PCSK9环肽抑制剂及其制备方法和用途
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
LAI, Yingjie
XIONG, Jinfeng
XIAO, Wanlong
LIU, Hanbin
DENG, Shenglu
ZHOU, Shengfu
ZHANG, Cairong
CHEN, Zhiwei
Priority Data
202411584661.3
06.11.2024
CN
202411756566.7
02.12.2024
CN
202511144048.4
14.08.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1807 | |
| EPO | Filing, Examination, Granting | 12086 | |
| Japan | Filing, Examination, Granting | 2001 | |
| South Korea | Filing, Examination, Granting | 1871 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,505
Contact Us
Abstract[English]
A PCSK9 cyclic peptide inhibitor or a stereoisomer, a racemate, or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a use thereof. Compound (I) disclosed herein has good PCSK9 inhibitory activity and can be used for treating diseases such as hyperlipidemia.[French]
Un inhibiteur peptidique cyclique de PCSK9, ou un stéréoisomère, un racémate ou un sel pharmaceutiquement acceptable de celui-ci, son procédé de préparation et son utilisation. Le composé (I) divulgué dans la présente invention présente une bonne activité inhibitrice de PCSK9 et peut être utilisé pour traiter des maladies telles que l'hyperlipidémie.[Chinese]
一种PCSK9环肽抑制剂，或其立体异构体、消旋体或其药学上可接受的盐，及其制备方法和用途，化合物(I)具有很好的PCSK9抑制活性，可用于治疗高脂血症等疾病。